IBDEI12T ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,17486,1,4,0)
 ;;=4^R94.5
 ;;^UTILITY(U,$J,358.3,17486,2)
 ;;=^5019742
 ;;^UTILITY(U,$J,358.3,17487,0)
 ;;=R94.6^^61^787^24
 ;;^UTILITY(U,$J,358.3,17487,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17487,1,3,0)
 ;;=3^Abnormal Thyroid Function Studies
 ;;^UTILITY(U,$J,358.3,17487,1,4,0)
 ;;=4^R94.6
 ;;^UTILITY(U,$J,358.3,17487,2)
 ;;=^5019743
 ;;^UTILITY(U,$J,358.3,17488,0)
 ;;=R94.7^^61^787^5
 ;;^UTILITY(U,$J,358.3,17488,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17488,1,3,0)
 ;;=3^Abnormal Endocrine Function Studies NEC
 ;;^UTILITY(U,$J,358.3,17488,1,4,0)
 ;;=4^R94.7
 ;;^UTILITY(U,$J,358.3,17488,2)
 ;;=^5019744
 ;;^UTILITY(U,$J,358.3,17489,0)
 ;;=R94.31^^61^787^4
 ;;^UTILITY(U,$J,358.3,17489,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17489,1,3,0)
 ;;=3^Abnormal EKG
 ;;^UTILITY(U,$J,358.3,17489,1,4,0)
 ;;=4^R94.31
 ;;^UTILITY(U,$J,358.3,17489,2)
 ;;=^5019739
 ;;^UTILITY(U,$J,358.3,17490,0)
 ;;=R97.0^^61^787^71
 ;;^UTILITY(U,$J,358.3,17490,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17490,1,3,0)
 ;;=3^Elevated Carcinoembryonic Antigen 
 ;;^UTILITY(U,$J,358.3,17490,1,4,0)
 ;;=4^R97.0
 ;;^UTILITY(U,$J,358.3,17490,2)
 ;;=^5019746
 ;;^UTILITY(U,$J,358.3,17491,0)
 ;;=R97.1^^61^787^70
 ;;^UTILITY(U,$J,358.3,17491,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17491,1,3,0)
 ;;=3^Elevated Cancer Antigen 125
 ;;^UTILITY(U,$J,358.3,17491,1,4,0)
 ;;=4^R97.1
 ;;^UTILITY(U,$J,358.3,17491,2)
 ;;=^5019747
 ;;^UTILITY(U,$J,358.3,17492,0)
 ;;=R97.8^^61^787^25
 ;;^UTILITY(U,$J,358.3,17492,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17492,1,3,0)
 ;;=3^Abnormal Tumor Markers NEC
 ;;^UTILITY(U,$J,358.3,17492,1,4,0)
 ;;=4^R97.8
 ;;^UTILITY(U,$J,358.3,17492,2)
 ;;=^5019749
 ;;^UTILITY(U,$J,358.3,17493,0)
 ;;=R93.1^^61^787^17
 ;;^UTILITY(U,$J,358.3,17493,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17493,1,3,0)
 ;;=3^Abnormal Findings on Dx Imaging of Heart/Cor Circ
 ;;^UTILITY(U,$J,358.3,17493,1,4,0)
 ;;=4^R93.1
 ;;^UTILITY(U,$J,358.3,17493,2)
 ;;=^5019714
 ;;^UTILITY(U,$J,358.3,17494,0)
 ;;=R68.83^^61^787^51
 ;;^UTILITY(U,$J,358.3,17494,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17494,1,3,0)
 ;;=3^Chills w/o Fever
 ;;^UTILITY(U,$J,358.3,17494,1,4,0)
 ;;=4^R68.83
 ;;^UTILITY(U,$J,358.3,17494,2)
 ;;=^5019555
 ;;^UTILITY(U,$J,358.3,17495,0)
 ;;=R68.2^^61^787^66
 ;;^UTILITY(U,$J,358.3,17495,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17495,1,3,0)
 ;;=3^Dry Mouth,Unspec
 ;;^UTILITY(U,$J,358.3,17495,1,4,0)
 ;;=4^R68.2
 ;;^UTILITY(U,$J,358.3,17495,2)
 ;;=^5019552
 ;;^UTILITY(U,$J,358.3,17496,0)
 ;;=R09.02^^61^787^92
 ;;^UTILITY(U,$J,358.3,17496,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17496,1,3,0)
 ;;=3^Hypoxemia
 ;;^UTILITY(U,$J,358.3,17496,1,4,0)
 ;;=4^R09.02
 ;;^UTILITY(U,$J,358.3,17496,2)
 ;;=^332831
 ;;^UTILITY(U,$J,358.3,17497,0)
 ;;=R39.81^^61^787^96
 ;;^UTILITY(U,$J,358.3,17497,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17497,1,3,0)
 ;;=3^Incontinence d/t Cognitive Imprmt/Svr Disability/Mobility
 ;;^UTILITY(U,$J,358.3,17497,1,4,0)
 ;;=4^R39.81
 ;;^UTILITY(U,$J,358.3,17497,2)
 ;;=^5019349
 ;;^UTILITY(U,$J,358.3,17498,0)
 ;;=R29.6^^61^787^151
 ;;^UTILITY(U,$J,358.3,17498,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,17498,1,3,0)
 ;;=3^Repeated Falls
 ;;^UTILITY(U,$J,358.3,17498,1,4,0)
 ;;=4^R29.6
 ;;^UTILITY(U,$J,358.3,17498,2)
 ;;=^5019317
 ;;^UTILITY(U,$J,358.3,17499,0)
 ;;=R44.1^^61^787^166
